Meinian Health: In the next 3 years, the company will acquire the in vitro high-quality medical examination center in an orderly manner_ Securities Times Network

Securities Times e company news, Meinian Health said during institutional research that as the company’s teams and operating environments in various cities gradually mature, the company will orderly acquire in vitro high-quality medical examination centers in the next three years, and continuously optimize the store structure. There are three main driving factors for the sustainable growth of the company in the future: one is endogenous growth through the release of production capacity, human efficiency, and area efficiency; the second is the driving force for growth shaped by the company’s innovative product strength; the third is the participation of in vitro stores. Controlled growth. The company has a relatively clear plan for parameter change control, which is considered from two perspectives: first, the entire operation end of the store, including medical quality, service, and customer repurchase rate; second, the overall profitability and growth status of the past few years, including The performance forecast for the next three years will help the company’s overall market share, etc.